glp 1 brain Hunting for heroes: neurons mediating GLP-1R agonists in obesity treatment Glucagon-like Peptide-1 Receptor Agonists: Possible

Byetta is also a GLP-1 drug, but the two medications are not the same

Among the numerous beneficial effects mediated by GLP-1R agonists are regulation of blood glucose, lowering of body weight via inhibition of food intake and the decrement of gastric motility, stimulation of cell proliferation, reduction of inflammation and apoptosis, improvement of cardiovascular function, and neuroprotection

Consider: Reduced red meat intake Reduced protein intake Reduced whole grains Reduced vegetable intake Reduced fat intake If YES Intake-related micronutrient risk increases If NO Risk remains lower Step 4: Are Symptoms Present

Abbass NJ, Nahlawi R, Shaia JK, Allan KC, Kaelber DC, Talcott KE, et al

6 For adults with heart disease and obesity or overweight, along with a reduced-calorie diet and increased physical activity